BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 412503)

  • 1. Inhibition of a mixed function oxidase system and consequent increase in potency of carbaryl by butylated hydroxyanisole in the housefly.
    Ciaccio EI; Boyek TJ
    Biochem Pharmacol; 1977 Dec; 26(23):2315-8. PubMed ID: 412503
    [No Abstract]   [Full Text] [Related]  

  • 2. Interactions between ethanol metabolism and mixed-function oxidation in perfused rat liver: inhibition of p-nitroanisole O-demethylation.
    Reinke LA; Kauffman FC; Belinsky SA; Thurman RG
    J Pharmacol Exp Ther; 1980 Apr; 213(1):70-8. PubMed ID: 6987376
    [No Abstract]   [Full Text] [Related]  

  • 3. Mechanism of inhibition of mixed-function oxidation by ethanol.
    Reinke LA; Belinsky SA; Kauffman FC; Thurman RG
    Adv Exp Med Biol; 1980; 132():151-61. PubMed ID: 7424703
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of 2(3)-tert-butyl-4-hydroxyanisole administration on the activities of several hepatic microsomal and cytoplasmic enzymes in mice.
    Cha YN; Bueding E
    Biochem Pharmacol; 1979 Jun; 28(12):1917-21. PubMed ID: 454464
    [No Abstract]   [Full Text] [Related]  

  • 5. Carbaryl synergism by substituted 1,3-benzodioxoles and related compounds and inhibition of mixed function oxidase.
    Desmarchelier J; Krieger RI; Lee PW; Fukuto TR
    J Econ Entomol; 1973 Jun; 66(3):631-8. PubMed ID: 4197039
    [No Abstract]   [Full Text] [Related]  

  • 6. Protective effects of butylated hydroxyanisole and its analogs on the lung toxicity of butylated hydroxytoluene in mice.
    Mizutani T
    Res Commun Chem Pathol Pharmacol; 1985 Oct; 50(1):125-33. PubMed ID: 4081305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of inhibition of microsomal drug metabolism by imidazole.
    Hajek KK; Cook NI; Novak RF
    J Pharmacol Exp Ther; 1982 Oct; 223(1):97-104. PubMed ID: 7120133
    [No Abstract]   [Full Text] [Related]  

  • 8. Enhancement of O-dealkylation in mouse liver by dietary administrations of BHA and BHT: studies with isolated perfused livers and hepatic microsomes.
    Ji SC; Conway JG; Thurman RG; Cha YN
    Yonsei Med J; 1986; 27(2):106-13. PubMed ID: 3092476
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of butylated hydroxyanisole (BHA) and butylated hydroxytoluene (BHT) on metabolism of N,N-dimethyl-4-aminoazobenzene (DAB) by rat liver microsomes.
    Levine WG
    Res Commun Chem Pathol Pharmacol; 1984 Oct; 46(1):113-20. PubMed ID: 6438741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benzo(a)pyrene free-radicals formation in the presence of butylated hydroxyanisole and their possible importance in carcinogenesis.
    Krzywanska E; Piekarski L
    Neoplasma; 1977; 24(4):395-400. PubMed ID: 198689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of promutagen activation by the antioxidants butylated hydroxyanisole and butylated hydroxytoluene.
    McKee RH; Tometsko AM
    J Natl Cancer Inst; 1979 Aug; 63(2):473-7. PubMed ID: 287836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of butylated hydroxyanisole on microsomal monooxygenase and drug metabolism.
    Peng RX; Lewis KF; Yang CS
    Zhongguo Yao Li Xue Bao; 1986 Mar; 7(2):157-61. PubMed ID: 2946156
    [No Abstract]   [Full Text] [Related]  

  • 13. Influence of butylated hydroxyanisole on oocyte depletion induced by 7,12-dimethylbenz(a)anthracene in mice.
    Selvan RS; Rao AR
    Indian J Exp Biol; 1985 Jun; 23(6):320-2. PubMed ID: 3935576
    [No Abstract]   [Full Text] [Related]  

  • 14. Short time interval effects of butylated hydroxyanisole on the metabolism of benzo(a)pyrene.
    Lam LK; Fladmoe AV; Hochalter JB; Wattenberg LW
    Cancer Res; 1980 Aug; 40(8 Pt 1):2824-8. PubMed ID: 7388832
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of dietary butylated hydroxyanisole on the mouse hepatic monooxygenase system of nuclear and microsomal fractions.
    Hennig EE; Demkowicz-DobrzaƄski KK; Sawicki JT; Mojska H; Kujawa M
    Carcinogenesis; 1983 Oct; 4(10):1243-6. PubMed ID: 6311449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of butylated hydroxyanisole on acute hymenoxon and bitterweed poisoning.
    Kim HL; Anderson AC; Terry MK; Bailey EM
    Res Commun Chem Pathol Pharmacol; 1981 Aug; 33(2):365-8. PubMed ID: 7302385
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of butylated hydroxyanisole on Tetrahymena pyriformis.
    Surak JG; Bradley RL; Branen AL; Shrago E
    Food Cosmet Toxicol; 1976 Aug; 14(4):277-81. PubMed ID: 824187
    [No Abstract]   [Full Text] [Related]  

  • 18. Chemical dissection of the primary and secondary in vitro antibody responses with butylated hydroxyanisole and gallic acid.
    Archer DL; Wess JA
    Drug Chem Toxicol; 1979; 2(1-2):155-66. PubMed ID: 548251
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition by retinol and butylated hydroxyanisole of carcinogen-mediated increases in guanylate cyclase activity and guanosine 3':5'-monophosphate accumulation.
    Craven PA; DeRubertis FR
    Cancer Res; 1977 Nov; 37(11):4088-97. PubMed ID: 20225
    [No Abstract]   [Full Text] [Related]  

  • 20. Protective effects of butylated hydroxyanisole, ethoxyquin, and disulfiram on acute pyrrolizidine alkaloids poisoning in mice.
    Kim HL; Jones LP
    Res Commun Chem Pathol Pharmacol; 1982 May; 36(2):341-4. PubMed ID: 7100635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.